These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4074608)

  • 1. CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite.
    Nordin C; Bertilsson L; Siwers B
    Br J Clin Pharmacol; 1985 Oct; 20(4):411-3. PubMed ID: 4074608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C; Bertilsson L; Siwers B
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
    Nordin C; Bertilsson L
    Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF/plasma ratio of 10-hydroxynortriptyline is influenced by sex and body height.
    Nordin C
    Psychopharmacology (Berl); 1993; 113(2):222-4. PubMed ID: 7855185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
    Bertilsson L; Otani K; Dahl ML; Nordin C; Aberg-Wistedt A
    Pharmacol Toxicol; 1991 Feb; 68(2):100-3. PubMed ID: 1852713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak binding of 10-hydroxymetabolites of nortriptyline to rat brain muscarinic acetylcholine receptors.
    Wägner A; Ekqvist B; Bertilsson L; Sjöqvist F
    Life Sci; 1984 Sep; 35(13):1379-83. PubMed ID: 6482660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites.
    Malmgren R; Aberg-Wistedt A; Bertilsson L
    Psychopharmacology (Berl); 1987; 92(2):169-72. PubMed ID: 2440073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.
    Dahl ML; Bertilsson L; Nordin C
    Psychopharmacology (Berl); 1996 Feb; 123(4):315-9. PubMed ID: 8867869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio.
    Nordin C; Siwers B; Benitez J; Bertilsson L
    Br J Clin Pharmacol; 1985 Jun; 19(6):832-5. PubMed ID: 4027124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study.
    Kin NM; Klitgaard N; Nair NP; Amin M; Kragh-Sorensen P; Schwariz G; Ahmed SK; Holm P; Katona C; Stage K
    Neuropsychopharmacology; 1996 Jul; 15(1):1-6. PubMed ID: 8797186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of nortriptyline and its E-10-hydroxy metabolite for muscarinic receptors.
    Nilvebrant L; Nordin C
    Pharmacol Toxicol; 1991 Jan; 68(1):64-7. PubMed ID: 2008414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 10-hydroxynortriptyline in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
    Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB; Linnet K
    Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Little anticholinergic effect of E-10-hydroxynortriptyline compared with nortriptyline in healthy subjects.
    Nordin C; Bertilsson L; Otani K; Widmark A
    Clin Pharmacol Ther; 1987 Jan; 41(1):97-102. PubMed ID: 3802713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nortriptyline and its 10-hydroxy metabolite on plasma noradrenaline (NA) concentrations, heart rate and blood pressure during intravenous NA infusion.
    Nordin C; Collste P; Otani K; Scheinin M
    Methods Find Exp Clin Pharmacol; 1987 Oct; 9(10):691-6. PubMed ID: 2964548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
    Nordin C; Bertilsson L; Dahl ML; Resul B; Toresson G; Sjöqvist F
    Psychopharmacology (Berl); 1991; 103(3):287-90. PubMed ID: 2057534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
    Bertilsson L; Nordin C; Otani K; Resul B; Scheinin M; Siwers B; Sjöqvist F
    Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships among nortriptyline, 10-OH(E)nortriptyline, and 10-OH(Z)nortriptyline steady-state plasma levels and nortriptyline dosage.
    Lukey BJ; Jones DR; Wright JH; Hurst HE
    Ther Drug Monit; 1989; 11(3):221-7. PubMed ID: 2728080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
    Woolhouse NM; Adjepon-Yamoah KK; Mellström B; Hedman A; Bertilsson L; Sjöqvist F
    Clin Pharmacol Ther; 1984 Sep; 36(3):374-8. PubMed ID: 6467797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma binding variations of amitriptyline and nortriptyline.
    Pike E; Skuterud B
    Clin Pharmacol Ther; 1982 Aug; 32(2):228-34. PubMed ID: 7094510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.